UnknownNot Applicable

International Registry for ASD Closure by Using the Occlutech®Flex II Device in More Than 2000 Patients

2,000 participantsStarted 2016-07

Plain-language summary

The IRFACODE II study will evaluate the performance and safety of the Occlutech® Flex II device in patients with closure of secundum atrial septal defects (ASD II).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: ASD for device closure \- Exclusion Criteria: * life expectancy \< 12 months * participating in another study

What they're measuring

number of erosions

Timeframe: minimum 1 year

Trial details

NCT IDNCT02766569

SponsorLudwig-Maximilians - University of Munich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-07

View on ClinicalTrials.gov More Atrial Septal Defect trials